Metsera (MTSR) Earnings Date & Reports

Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MTSR is expected to report earnings to rise 22.73% to -81 cents per share on December 03

Q3'25

Est.

$-0.81

Q2'25

Missed

by $0.03

The last earnings report on July 28 showed earnings per share of -66 cents, missing the estimate of -62 cents. With 2.31M shares outstanding, the current market capitalization sits at 5.53B.

View a ticker or compare two or three

Compare

MTSR

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For MTSR
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MTSR showed earnings on July 28, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details